FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Jul 4, 2024 0 315
usnews Feb 29, 2024 0 302
usnews Jul 4, 2024 0 301
usnews Jul 4, 2024 0 295
usnews Jul 12, 2023 0 285